Zheng W, Yang Z, Song P, Sun Y, et al. SHP2 inhibition mitigates adaptive resistance to MEK inhibitors in KRAS-mutant gastric cancer through the suppression of KSR1 activity. Cancer Lett 2022 Dec 6:216029. doi: 10.1016/j.canlet.2022.216029.
PMID: 36493900